Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2446)
All Articles published online
|
Nov 7, 2006 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World J Gastroenterol 2006; 12(41): 6639-6645 [PMID: 17075977 DOI: 10.3748/wjg.v12.i41.6639] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i41/6639.htm |
| Number | Citing Articles |
| 1 |
Roger Flores‐Costa, José Alcaraz‐Quiles, Esther Titos, Cristina López‐Vicario, Mireia Casulleras, Marta Duran‐Güell, Bibiana Rius, Alba Diaz, Katherine Hall, Courtney Shea, Renee Sarno, Mark Currie, Jaime L Masferrer, Joan Clària. The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis. British Journal of Pharmacology 2018; 175(6): 953 doi: 10.1111/bph.14137
|
| 2 |
Ya Zhang, Hang Zhao, Hua Li, Wei Cao, Fang Wang, Tian Zhang, Si-Wang Wang. Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice. Molecules 2017; 22(5): 754 doi: 10.3390/molecules22050754
|
| 3 |
Ebtehal El-Demerdash, Somaia A. Abdel-Sattar, Wesam M. El-Bakly, Eman A. Mohamed. Antifibrotic Effects of Carvedilol and Impact of Liver Fibrosis on Carvedilol Pharmacokinetics in a Rat model. European Journal of Drug Metabolism and Pharmacokinetics 2017; 42(5): 767 doi: 10.1007/s13318-016-0391-9
|
| 4 |
Istvan Kovanecz, Amarnath Rambhatla, Monica G. Ferrini, Dolores Vernet, Sandra Sanchez, Jacob Rajfer, Nestor Gonzalez‐Cadavid. Chronic daily tadalafil prevents the corporal fibrosis and veno‐occlusive dysfunction that occurs after cavernosal nerve resection. BJU International 2008; 101(2): 203 doi: 10.1111/j.1464-410X.2007.07223.x
|
| 5 |
Yusuf Ergün, Ergül Belge Kurutaş, Burhan Özdil, Ramazan Güneşaçar, Yılmaz Ergün. Evaluation of nitrite/nitrate levels in relation to oxidative stress parameters in liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2011; 35(4): 303 doi: 10.1016/j.clinre.2010.12.009
|
| 6 |
Edyta Maslak, Aleksandra Gregorius, Stefan Chlopicki. Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver. Pharmacological Reports 2015; 67(4): 689 doi: 10.1016/j.pharep.2015.04.010
|
| 7 |
Shinichiro Fukuhara, Akira Tsujimura, Hidenobu Okuda, Keisuke Yamamoto, Tetsuya Takao, Yasushi Miyagawa, Norio Nonomura, Akihiko Okuyama. Vardenafil and Resveratrol Synergistically Enhance the Nitric Oxide/Cyclic Guanosine Monophosphate Pathway in Corpus Cavernosal Smooth Muscle Cells and its Therapeutic Potential for Erectile Dysfunction in the Streptozotocin-Induced Diabetic Rat: Preliminary Findings. The Journal of Sexual Medicine 2011; 8(4): 1061 doi: 10.1111/j.1743-6109.2010.02193.x
|
| 8 |
Rory P. Cunningham, Ryan D. Sheldon, R. Scott Rector. The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00767
|
| 9 |
Rafael Vercelino, Irene Crespo, Gabriela F. P. de Souza, Maria Jose Cuevas, Marcelo G. de Oliveira, Norma Possa Marroni, Javier González-Gallego, María Jesús Tuñón. S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats. Journal of Molecular Medicine 2010; 88(4): 401 doi: 10.1007/s00109-009-0577-6
|
| 10 |
Hala Salah Abdel-Kawy. Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats. Drug and Chemical Toxicology 2021; 44(1): 101 doi: 10.1080/01480545.2019.1576718
|
| 11 |
Claire Edwards, Hong-Qiang Feng, Christopher Reynolds, Lan Mao, Don C. Rockey. Effect of the nitric oxide donor V-PYRRO/NO on portal pressure and sinusoidal dynamics in normal and cirrhotic mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 294(6): G1311 doi: 10.1152/ajpgi.00368.2007
|
| 12 |
Csaba Szabo. Burger's Medicinal Chemistry and Drug Discovery. 2010; : 265 doi: 10.1002/0471266949.bmc178
|
| 13 |
Sureeporn Lomakool, Khomsan Ruangrit, Itthipon Jeerapan, Yingmanee Tragoolpua, Chayakorn Pumas, Sirasit Srinuanpan, Jeeraporn Pekkoh, Kritsana Duangjan. Biological activities and phytochemicals profiling of different cyanobacterial and microalgal biomass. Biomass Conversion and Biorefinery 2023; 13(5): 4195 doi: 10.1007/s13399-021-01974-0
|
| 14 |
Meritxell Perramón, María Navalón-López, Guillermo Fernández-Varo, Alazne Moreno-Lanceta, Rocío García-Pérez, Joana Faneca, Mario López-Moya, Cristina Fornaguera, Judith García-Villoria, Manuel Morales-Ruiz, Pedro Melgar-Lesmes, Salvador Borrós, Wladimiro Jiménez. Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats. Biomedicine & Pharmacotherapy 2024; 171: 116143 doi: 10.1016/j.biopha.2024.116143
|
| 15 |
Edyta Kus, Krzysztof Jasiński, Tomasz Skórka, Izabela Czyzynska-Cichon, Stefan Chlopicki. Short-term treatment with hepatoselective NO donor V-PYRRO/NO improves blood flow in hepatic microcirculation in liver steatosis in mice. Pharmacological Reports 2018; 70(3): 463 doi: 10.1016/j.pharep.2017.11.019
|
| 16 |
Sarit Anavi, Michal Eisenberg-Bord, Michal Hahn-Obercyger, Olga Genin, Mark Pines, Oren Tirosh. The role of iNOS in cholesterol-induced liver fibrosis. Laboratory Investigation 2015; 95(8): 914 doi: 10.1038/labinvest.2015.67
|
| 17 |
Daniel A. Langer, Amitava Das, David Semela, Ningling Kang-Decker, Helen Hendrickson, Steven F. Bronk, Zvonimir S. Katusic, Gregory J. Gores, Vijay H. Shah. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology 2008; 47(6): 1983 doi: 10.1002/hep.22285
|
| 18 |
Edyta Maslak, Piotr Zabielski, Kamila Kochan, Kamil Kus, Agnieszka Jasztal, Barbara Sitek, Bartosz Proniewski, Tomasz Wojcik, Katarzyna Gula, Agnieszka Kij, Maria Walczak, Małgorzata Baranska, Adrian Chabowski, Ryan J. Holland, Joseph E. Saavedra, Larry K. Keefer, Stefan Chlopicki. The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet. Biochemical Pharmacology 2015; 93(3): 389 doi: 10.1016/j.bcp.2014.12.004
|